These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

200 related items for PubMed ID: 7476655

  • 21. [Tumor marker in ovarian cancer].
    Komai K, Nishida T.
    Gan To Kagaku Ryoho; 2002 Mar; 29(3):481-6. PubMed ID: 11915744
    [Abstract] [Full Text] [Related]

  • 22. CA-125 level preoperative assessment in early and advanced ovarian carcinoma.
    Raspollini MR.
    Gynecol Oncol; 2007 Nov; 107(2):356-7; author reply 357-8. PubMed ID: 17716712
    [No Abstract] [Full Text] [Related]

  • 23. Current approaches to diagnosis and treatment of ovarian germ cell malignancies.
    Fishman DA, Schwartz PE.
    Curr Opin Obstet Gynecol; 1994 Feb; 6(1):98-104. PubMed ID: 8180359
    [Abstract] [Full Text] [Related]

  • 24. Conservative treatment of big yolk sac tumour of the ovary in young girl.
    Beurdeley M, Gauthier T, Piguet C, Fourcade L.
    J Visc Surg; 2010 Aug; 147(4):e265-7. PubMed ID: 20920902
    [Abstract] [Full Text] [Related]

  • 25. Hypercalcemic-type ovarian small cell carcinoma with unique CD34 expression.
    Inadome Y, Shibata T, Suzuki K, Tsugata M, Shimabukuro K, Noguchi M.
    Pathol Int; 2009 Oct; 59(10):766-8. PubMed ID: 19788625
    [No Abstract] [Full Text] [Related]

  • 26. Ovarian undifferentiated carcinoma resembling giant cell carcinoma of the lung.
    Yasunaga M, Ohishi Y, Nishimura I, Tamiya S, Iwasa A, Takagi E, Inoue T, Yahata H, Kobayashi H, Wake N, Tsuneyoshi M.
    Pathol Int; 2008 Apr; 58(4):244-8. PubMed ID: 18324918
    [Abstract] [Full Text] [Related]

  • 27. Primary ovarian sarcoma: analysis of prognostic variables and the role of surgical cytoreduction.
    Sood AK, Sorosky JI, Gelder MS, Buller RE, Anderson B, Wilkinson EJ, Benda JA, Morgan LS.
    Cancer; 1998 May 01; 82(9):1731-7. PubMed ID: 9576296
    [Abstract] [Full Text] [Related]

  • 28. An unusual presentation of Stage III ovarian carcinoma.
    Noor S, Khan R, Hollingworth A.
    J Obstet Gynaecol; 2005 Aug 01; 25(6):619-20. PubMed ID: 16234164
    [No Abstract] [Full Text] [Related]

  • 29. [Tumor-associated antigen CA-125 in patients with ovarian cancer receiving various combinations of therapy].
    Akhmedova SA, Sergeeva NS, Marshutina NV, Mishunina MP, Novikova EG.
    Vopr Onkol; 2003 Aug 01; 49(1):95-8. PubMed ID: 12715380
    [Abstract] [Full Text] [Related]

  • 30. Prognostic significance of CA 125 and TPS levels after 3 chemotherapy courses in ovarian cancer patients.
    van Dalen A, Favier J, Burges A, Hasholzner U, de Bruijn HW, Dobler-Girdziunaite D, Dombi VH, Fink D, Giai M, McGing P, Harlozinska A, Kainz C, Markowska J, Molina R, Sturgeon C, Bowman A, Einarsson R.
    Gynecol Oncol; 2000 Dec 01; 79(3):444-50. PubMed ID: 11104617
    [Abstract] [Full Text] [Related]

  • 31. Current aspects of adjuvant therapy of early stage ovarian cancer.
    McGuire WP.
    Zentralbl Gynakol; 1998 Dec 01; 120(3):93-7. PubMed ID: 9556898
    [Abstract] [Full Text] [Related]

  • 32. [Remote results of the standard ovary cancer treatment].
    Ushakov II, Mel'ko AI, Kira EF, Ermolinskiĭ II.
    Voen Med Zh; 2005 Nov 01; 326(11):36-8. PubMed ID: 16404905
    [No Abstract] [Full Text] [Related]

  • 33. Management of epithelial ovarian tumors of low malignant potential.
    Trimble CL, Trimble EL.
    Gynecol Oncol; 1994 Dec 01; 55(3 Pt 2):S52-61. PubMed ID: 7835812
    [Abstract] [Full Text] [Related]

  • 34. [Drug therapy of ovarian carcinoma].
    Dittrich C.
    Wien Med Wochenschr; 1996 Dec 01; 146(1-2):23-34. PubMed ID: 8835492
    [Abstract] [Full Text] [Related]

  • 35. Predictive value of the combined serum CA 125 and TPS during chemotherapy and before second-look laparotomy in epithelial ovarian cancer.
    Senapad S, Neungton S, Thirapakawong C, Suphanit I, Hangsubcharoen M, Thamintorn K.
    Anticancer Res; 2000 Dec 01; 20(2B):1297-300. PubMed ID: 10810438
    [Abstract] [Full Text] [Related]

  • 36. ACR Appropriateness Criteria on staging and follow-up of ovarian cancer.
    Javitt MC.
    J Am Coll Radiol; 2007 Sep 01; 4(9):586-9. PubMed ID: 17845961
    [Abstract] [Full Text] [Related]

  • 37. Granulosa cell tumor of the ovary: tumor review.
    Koukourakis GV, Kouloulias VE, Koukourakis MJ, Zacharias GA, Papadimitriou C, Mystakidou K, Pistevou-Gompaki K, Kouvaris J, Gouliamos A.
    Integr Cancer Ther; 2008 Sep 01; 7(3):204-15. PubMed ID: 18815151
    [Abstract] [Full Text] [Related]

  • 38. Significance of the tumour markers CA 125 II, CA 72-4, CASA and CYFRA 21-1 in ovarian carcinoma.
    Hasholzner U, Baumgartner L, Stieber P, Meier W, Hofmann K, Fateh-Moghadam A.
    Anticancer Res; 1994 Sep 01; 14(6B):2743-6. PubMed ID: 7532929
    [Abstract] [Full Text] [Related]

  • 39. [Adjuvant measures after primary surgery of ovarian cancer].
    Bauknecht T.
    Gynakologe; 1994 Apr 01; 27(2):70-5. PubMed ID: 8039745
    [No Abstract] [Full Text] [Related]

  • 40. Recent advances in the management of women with ovarian cancer.
    Eltabbakh GH.
    Minerva Ginecol; 2004 Feb 01; 56(1):81-9. PubMed ID: 14973412
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.